globalbridges

1. June 2010 to February 2013 www.globalbridges.org

2. Global Bridges Mission Create and mobilize a global network of healthcare providers and organizations dedicated to advancing effective tobacco dependence treatment and advocating for effective tobacco control policy. www.globalbridges.org

3. Global Bridges Objectives • Build a network • Create opportunities to share treatment and advocacy expertise among network members within and across regions • Provide training • State-of-the-art, evidence-based training in tobacco dependence treatment and advocacy • Article 14 implementation • Facilitate the implementation of FCTC Article 14 in every nation • Sustain the mission • Ensure the long-term financial sustainability of the initiative

4. Clinton Global Initiative • Created in 2005 by President Bill Clinton “to help turn good intentions into real actions and results.” • Convenes over 1,000 global leaders to devise and implement innovative solutions to some of the world’s most pressing problems • CGI members make commitments to improve the lives of people across the globe

5. GB Accomplishments Summary • Since April 2011, Regional Partners have trained over 1575 HCPs from 53countries • Over 18000 person-hours of training, reaching thousands of patients • Presented at national, regional, and global meetings with combined attendance of over 22,000 • www.globalbridges.orglaunched in 6 languages • 724 members have joined via website • Active collaborations with ATTUD, treatobacco.net, Global Nurses Network, American Academy of Pediatrics, Global Smokefree Partnership, Hong Kong Dept of Health, INWAT, American Association of Anesthesiologists, and others

6. Global Bridges Regional Partners Middle East Region Feras Hawari, MD – Regional Director Latin America Region Gustavo Zabert, MD – Regional Director Beatriz Champagne, PhD – IAHF Exec Director Africa Region Lekan Ayo-Yusuf, BDS, MPH, PhD – Regional Director

7. Hong Kong/China • Mayo Clinic has worked with Hong Kong Dept of Health and Hospital Authority to develop and host TTS training series • Co-branded curriculum in English and Mandarin • Support from Hong Kong Academy of Medicine – 15 colleges • HK DoH recently became WHO Collaborating center • Over 100 Healthcare professionals trained to date • Positions GB to expand into mainland China • Seeking dedicated regional partner and funding

8. Global Bridges in Europe • National Centre for Smoking Cessation Training • In 2012, conducted situation analysis of 52 countries, with special attention to Eastern Europe • Expert Roundtable participation from Czech Republic, Russia, Azerbaijan, Georgia, Portugal, Spain • Conclusion: further development of regional network is crucially important • 2013 program focus on expanding and engaging network, largely through website and selected conferences • Also offering treatment support for smoking physicians

9. Global Bridges 2013 • Continue work in Africa, Middle East, Latin America/Caribbean, Europe • Improve evaluation and follow-up • Focus on countries with commitment to implement FCTC • Evaluate and Communicate impact • Network Analysis • Minimal Dataset • Presentations at major medical meetings • Launch Distance Learning program • Working with CAMH/University of Toronto • Initial languages: Spanish & Arabic • Assessment of 40+ English-language programs

10. Global Bridges 2013 Events

12. GB/CAMH Collaboration • Distance learning curriculum • Learning objectives • Introductory module • Long term plan • Environmental scan • Review of all English language on-line learning for tobacco dependence • Standardized approach • Publication of results

13. GB/CAMH Distance Learning • Goal: provide accredited training on tobacco dependence treatment through a series of innovative distance-learning modules • Target Audience: Healthcare professionals interested in treating tobacco dependence Regional focus- Middle East & Latin America • Language focus- Spanish and Arabic • Specialty focus

14. Distance Learning Objectives • Describe important adverse health consequences of tobacco use • Describe the neurobiology of tobacco dependence • Recognize the importance of integrating tobacco dependence treatment into clinical practice • Apply key systems-level modifications to support screening and assessment for all tobacco users • Implement basic, brief behavioral and motivational interventions for tobacco dependence • Access additional learning resources on tobacco dependence treatment

15. Learning Objectives-Introductory Module Background: global tobacco use and adverse health effects Neurobiology of tobacco dependence Screening and assessment for all tobacco users Brief behavioral and motivational interventions for tobacco dependence Basic Pharmacotherapy

16. Evaluation At inception: • # (unique) learners/increase in reach • pre-post learning assessment (self-report) • pre-post evaluation of knowledge • Learner satisfaction with course Over time: • Learner progress; portfolio of learning • Impact on clinician behavior, patient outcomes, public health

17. Topic Map PATIENTS WITH COMORBIDITY TOBACCO PRODUCTS PHARMACOTHERAPY INTRO MODULE FCTC AND ADVOCACY SCREENING & ASSESSMENT PSYCHOSOCIAL INTERVENTION

18. www.globalbridges.org